Palvella Therapeutics Strengthens Leadership Team with Appointment of Rare Disease Commercial Leader Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services
Go back to Palvella Therapeutics Strengthens Leadership Team with Appointment of Rare Disease Commercial Leader Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services| (NASDAQ: KRYS) | Delayed: 317.97 -3.58 (1.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $321.55 | 52 Week High | $ | |||
| Open | $331.49 | 52 Week Low | $ | |||
| Day High | $331.49 | P/E | N/A | |||
| Day Low | $316.54 | EPS | $ | |||
| Volume | 313,481 | |||||
| (NASDAQ: PVLA) | Delayed: 108.81 +2.43 (2.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $106.38 | 52 Week High | $ | |||
| Open | $106.82 | 52 Week Low | $ | |||
| Day High | $109.01 | P/E | N/A | |||
| Day Low | $104.77 | EPS | $ | |||
| Volume | 360,812 | |||||
